【2h】

Induction of hepatocellular carcinoma by in vivo gene targeting

机译:体内基因靶向诱导肝细胞癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The distinct phenotypic and prognostic subclasses of human hepatocellular carcinoma (HCC) are difficult to reproduce in animal experiments. Here we have used in vivo gene targeting to insert an enhancer-promoter element at an imprinted chromosome 12 locus in mice, thereby converting ∼1 in 20,000 normal hepatocytes into a focus of HCC with a single genetic modification. A 300-kb chromosomal domain containing multiple mRNAs, snoRNAs, and microRNAs was activated surrounding the integration site. An identical domain was activated at the syntenic locus in a specific molecular subclass of spontaneous human HCCs with a similar histological phenotype, which was associated with partial loss of DNA methylation. These findings demonstrate the accuracy of in vivo gene targeting in modeling human cancer and suggest future applications in studying various tumors in diverse animal species. In addition, similar insertion events produced by randomly integrating vectors could be a concern for liver-directed human gene therapy.
机译:人类肝细胞癌(HCC)的独特表型和预后亚类很难在动物实验中复制。在这里,我们已经使用体内基因靶向技术在小鼠的印迹12号染色体基因座上插入了一个增强子-启动子元件,从而通过单次基因修饰将20,000例正常肝细胞中的〜1个转化为HCC的焦点。在整合位点周围激活了一个包含多个mRNA,snoRNA和microRNA的300 kb染色体结构域。在具有相似组织学表型的自发人类HCC特定分子亚类的同位点上,一个相同的域被激活,这与DNA甲基化的部分丢失有关。这些发现证明了体内基因靶向在模拟人类癌症中的准确性,并暗示了在研究多种动物物种的各种肿瘤中的未来应用。另外,通过随机整合载体产生的类似插入事件可能是针对肝脏的人类基因治疗的关注点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号